Sleep medicine for the first year of life - PowerPoint Presentation

Slide1

Sleep medicine for the first year of life

Oleg Kouskov, MD, MCR

Director, Pediatric Sleep Services,

St Luke’s Sleep Medicine Institute

Slide2

Kids are not little adults

Slide3

“

Kids have their own special ability to see, to think and to feel, and there is nothing more stupid than try to substitute theirs with ours.”

Jean-Jack Rousseau

Slide4

Slide5

Staging

Sensorimotor birth to age 2. Children experience the world through movement and senses. Extremely egocentric, cannot perceive the world from others' viewpoints.

Preoperational 2-7

Concrete Operational 7-12

Formal operational – 12+

Slide6

There is only one step between me and a five year old. There is a horrendous distance between me and the newborn.

Leo Tolstoi

Slide7

What is normal?

Slide8

Sleep- wake regulation

Newborns do not have an established circadian rhythm, sleep is distributed throughout the day and night with each period of sleep short because of feeding frequency (Davis, 2004) After birth,there is progressive maturation of the circadian system outputs, with pronounced rhythms in sleepwake and hormone secretion generally developing after 2 months of age (Rivkees,2007).

At around 10-12 weeks of age, the circadian rhythm begins to emerge, and infant sleep becomes increasingly nocturnal

Night wakings are common in infancy and early childhood

Slide9

From Rivkees SA, Hofman PL, Fortman J. Newborn primate infants are entrained

by low intensity lighting. Proc Natl Acad Sci USA 1997;94(1):292–7

Slide10

Oskar G. Jenni, MDa,b,*, Mary A. Carskadon, PhDc, 2007

Slide11

adapted from Challamel M.J., Thirion M. and Appleton & Lange, Kandel, Schwartz, Jessell, Principles of Neural Science

Slide12

Sleep- wake regulation

Children’s ability to return to sleep unaided plays a major role in determining whether or not wakings will persist and become problematic (Touchette,2005)

The frequency of night wakings is one of the main factors by which parents judge the quality of their child’s sleep (Palmstierna,2008)

Sleep-wake patterns, driven by a complex interplay between biological processes, and environmental, behavioural and social factors, can

vary widely (Galland,2011)

Slide13

Slide14

Slide15

How to approach sleep complaints ?

Slide16

In my opinion, best article

in sleep medicine

Slide17

5-fingers approach

Circadian/environmental influences

Medication effects

General medical conditions

Psychosocial influencesPrimary sleep diagnoses

Slide18

Sleep environment

TV in the bedroom predicts sleep disturbance – like increase in SOL by 20 min average, increase in bedtime resistance, decrease in TST (National Sleep Foundation, 2004)

Bedsharing associated with increased nocturnal awakenings(Mc Kenna, 1994) Co sleeping increases from infancy, peaks at 4 yo, then decreases as child reaches 10 yo (Jenni, 2005)

Sharing room with siblings adversely affects sleep (NSF, 2004)

Slide19

Parental mental problems and sleep

Most data on depression. Infant and childhood sleep problems correlated with maternal depression (Hiscock 2001, Zukerman 1987). Relationships between maternal depression and kid’s sleep is bidirectional. Depressed moms are less likely to implement sleep schedule, bedtime routine or be emotionally vailable(McLearn,2006).

Paternal psychiatric history is highly correlated with dyssomnias (Liu, 2000)

Marital conflict associated with sleep problems (Sheikh, 2007)

Slide20

Parental problems and sleep

Family stress associated with lower SE and increased nightwakings. Suggested that distressed parents create disorganized environment and have less effective parental practices (Sadeh, 2001)

Parents who have difficulty setting or implementing limits consistently are more likely to have children with sleep disturbances (Owens-Stively, 1991)

Lower maternal education was associated with poor sleep (Rona, 1998).

Children of parents with higher education had highest sleep quality (Sadeh, 2000)

Slide21

Mothers with poorer mental health reported that their infants had more night waking and bedtime distress and were more bothered by these sleep issues.

Individual differences in maternal well-being may color mothers’ interpretations of infants’ sleep behaviors. It may be prudent to intervene to support maternal mental health when infants are referred for sleep problems.

Slide22

Effect of medical comorbidities

Acute problems like colds, otitis

Chronic medical conditions like asthma, epilepsy frequently disrupt sleep

Anticipatory anxiety for treatments

Frequent hospitalizationsFamily stress related to diseases

Slide23

Many of the sleep problems of infants are resolved by behavioral interventions and parental education

Slide24

Behavioral insomnia of childhood: typical scenario

9 m old, falls asleep while rocked in mom’s arms. Through the night wakes up multiple times, needs mom to come and rock back to sleep.

Key to treatment: teach to sleep independently

Slide25

What is sleep study?

Slide26

http://en.wikipedia.org/wiki/Polysomnography

Slide27

http://en.wikipedia.org/wiki/Polysomnography

Slide28

When should we order PSG in infants?

Slide29

Common indications

Evaluation for potential breathing disorders

Sometimes for parasomnias

RLS/PLMD

Evaluation of cardiorespiratory function in kids with neuromuscular and chronic lung diseasePAP/vent titrationTracheostomy decannulations

Slide30

Limited data are available regarding the clinical utility of PSG (1) in infants less than 12 months of age with suspected SRBD; (2) for evaluation of children with chronic respiratory disorders such as chronic obstructive or restrictive lung disease, and suspected SRBD; and (3) for therapeutic purposes including PAP titration, repeat PSG following AT or other surgical procedures, consideration of changes in mechanical ventilator management, decannulation of tracheostomy, and other uses. A small but useful group of papers confirmed the usefulness of PSG for initiation and titration of PAP in children with OSAS. However, the data do not address the optimal timing for repeat studies in children on PAP.

Slide31

The most relevant findings:

(1) recognition that the clinical history and physical examination are often poor predictors of respiratory PSG findings,

(2) preoperative PSG is helpful in predicting risk of perioperative complications, and

(3) preoperative PSG is often helpful in predicting persistence of OSA in a substantial minority of patients after AT. The latter issue is important because it may help identify children who require further treatment. However, the task force did not identify any prospective studies that specifically address whether clinical outcome following AT for treatment of OSA in children is improved in association with

routine performance of PSG before surgery in otherwise healthy children

Slide32

No studies/articles

It is likely that most infants with this entity are diagnosed based on the clinical history and observations in the nursery setting.

Clinically, these infants experience recurrent apneas with or without bradycardia and a variety of potential etiologies or comorbid conditions exist including prematurity, GER and other medical disorders, and neurological disorders.

Slide33

A Level 2 study reported that in subjects with respiratory dysfunction, GER was present in 75%; conversely, in subjects with GER, respiratory dysfunction was present in 45%.

In other studies, findings were variable, and there were a variety of methodological limitations.

Further investigations are needed to understand the diagnostic yield and clinical utility of lower esophageal pH monitoring during overnight PSG in infants.

Slide34

Two papers (1 Level 2 and 1 Level 4) provide limited data that addressed the potential clinical utility of PSG for evaluation of suspected CCHS. Further investigations may clarify the clinical utility and timing of PSG in suspected CCHS, the role of PSG in assessment of asymptomatic carriers of the PHOX2b mutation, and when periodic reevaluation may be necessary.

Slide35

PSG may have clinical utility in evaluating SRBD before and after surgical intervention, particularly if there is clinical concern for moderate to severe respiratory disturbance. However, it is not possible to confirm the clinical utility of PSG in this population of infants based on only one Level 4 paper.

Slide36

PSG does not provide sufficiently distinctive or predictive findings to support a routine clinical indication for PSG to determine risk of death due to SIDS.

This is an area of active investigation and future work with more sophisticated techniques that may lead to greater clinical utility of PSG.

Slide37

13 papers addressed the utility of PSG for ALTE

Two Level 3 and 1 Level 4 studies suggest that infants who experience an ALTE are at increased risk for SRBD because of facial dysmorphology, or other risk factors for SRBD. However, further evaluation is needed to assess the clinical utility of PSG in this population.

GER as well as nospecific or subtle abnormalities may be identified but it was not possible to estimate the diagnostic yield of PSG

In general the prognosis for recurrence of ALTE could not be predicted based on PSG findings, and a significant proportion of infants who experience an ALTE have a normal PSG

It is possible that PSG may be clinically useful in selected populations, particularly when there is clinical concern for upper airway obstruction or other forms of SRBD

Slide38

Healthy premature infants at or near term and almost ready for hospital discharge experience frequent, unsuspected adverse cardiorespiratory events.

There may be role for daytime nap PSG or nocturnal PSG in infants born either preterm or at term, for differentiation between normal and abnormal breathing, and cardiorespiratory differences of heart rate and blood pressure, and sleep position.

In 1 paper with Level 3 evidence, investigators concluded that full PSG provides the physiological data for proper diagnosis in young infants and that limited cardio respiratory studies can be misleading in this population. Another article with Level 2 evidence evaluated 14 infants with cyanotic breath-holding spells, and all subjects were found to have PSG abnormalities consistent with SRBD. This is a small exploratory study, but findings suggest that infants who present with cyanotic breath holding spells may require PSG to evaluate for SRBD.

Slide39

Sleep apnea in the first year of life

Slide40

Definition, AASM 2012: apnea

a. There is a drop in the peak signal excursion by ≥90% of pre-event baseline using an oronasal thermal sensor (diagnostic study), PAP device flow (titration study), or an

alternative

apnea sensor (diagnostic study).

b. The duration of the ≥90% drop in sensor signal lasts at least the minimum duration as specified by obstructive, mixed, or central apnea duration criteria.

c. The event meets respiratory effort criteria for obstructive, central or mixed apnea.

Slide41

Slide42

Definition, AASM 2012: apnea

2. Score an apnea as

obstructive

if it meets apnea criteria for at least the duration of 2 breaths during baseline breathing AND is associated with the presence of respiratory effort throughout the entire period of absent airflow.  

Slide43

Tracing from : Timothy F. Hoban, MDa,*, Ronald D. Chervin, MD, MS, 2007

Slide44

Slide45

Definition, AASM 2012: apnea

3. Score an apnea as

central

if it meets apnea criteria, is associated with absent inspiratory effort throughout the entire duration of the event AND at least one of the following is met:  

a. The event lasts ≥20 seconds.b. The event lasts at least the duration of two breaths during baseline breathing and is associated with an arousal or a ≥3% arterial oxygen desaturation.

c. The event is associated with a decrease in heart rate to less than 50 beats per minute for at least 5 seconds or less than 60 beats per minute for 15 seconds (infants under 1 year of age only).

Slide46

http://www-archive.thoracic.org/sections/education/sleep-fragments/quiz/arousal-triggered-respiratory-event.html

Slide47

Definition, AASM 2012: apnea

4. Score an apnea as

mixed

if it meets apnea criteria for at least the duration of 2 breaths during baseline breathing AND is associated with absent respiratory effort during one portion of the event AND the presence of inspiratory effort in another portion, regardless of which portion comes first.

Slide48

Definition, AASM 2012: hypopnea

1. Score a respiratory event as a hypopnea if ALL of the following criteria are met:N1  

a. The peak signal excursions drop by ≥30% of pre-event baseline using nasal pressure (diagnostic study), PAP device flow (titration study) or an

alternative

hypopnea sensor (diagnostic study). b. The duration of the ≥30% drop in signal excursion lasts for ≥2 breaths

c. There is a ≥3% oxygen desaturation from pre-event baseline or the event is associated with an arousal

Slide49

Central vs obstructive hypopnea

2. If electing to score obstructive hypopneas, score a hypopnea as

obstructive

if ANY of the following criteria are met:  

a. Snoring during the event b. Increased inspiratory flattening of the nasal pressure or PAP device flow signal compared to baseline breathing

c. Associated thoracoabdominal paradox occurs during the event but not during pre-event breathing

Slide50

Central vs obstructive hypopnea

3. If electing to score central hypopneas, score a hypopnea as

central

if NONE of the following criteria are met:  

a. Snoring during the event b. Increased inspiratory flattening of the nasal pressure or PAP device flow signal compared to baseline breathing

c. Associated thoracoabdominal paradox occurs during the event but not during pre-event breathing

Slide51

Slide52

Definition, AASM 2012: RERA

If electing to score respiratory effort-related arousals, score a respiratory event as a RERA if there is a sequence of breaths lasting ≥2 breaths (or the duration of two breaths during baseline breathing) when the breathing sequence is characterized by increasing respiratory effort, flattening of the inspiratory portion of the nasal pressure (diagnostic study) or PAP device flow (titration study) waveform, snoring, or an elevation in the end-tidal PCO2 leading to arousal from sleep when the sequence of  breaths does not meet criteria for an apnea or hypopnea.

Slide53

Periodic breathing

Score a respiratory event as periodic breathing if there are ≥3 episodes of central apnea lasting >3 seconds separated by ≤20 seconds of normal breathing

Slide54

Periodic breathing

Slide55

Million dollar question:

What is normal???

Slide56

Slide57

Slide58

Slide59

For obstructive apnea, < 1.0 per hour,

Mixed apnea, < 1.0 per hour.

For central apnea defined as cessation of respiratory efforts for more than 3 seconds,

- 45 per hour for 1-month-old infants,

- 30 per hour for 2-month-old infants, - 22 per hour for 3-month-old infants,

- 10 - 20 for the older age groups. For the desaturation episode defined as SpO2 less than 80% for any length of time:

- up to 14.7 episodes per hour for day 1,

- up to 41 episodes for day 4,

- up to 15.1 episodes for day 39.

Slide60

Slide61

Treatment

T+A

Supraglottoplasty

Positive Airway Pressure Therapy

OxygenTracheostomyLip-tongue adhesion

Mandibular distraction osteogenesisMidfacial advancementFronto facial distraction

Slide62

Slide63

Thank you!

Slide64

Questions?